Shi Si Yao Group’s Guangxiang Pharmaceutical and Guolong Pharmaceutical have both been included in Hebei Province’s list of “Specialized, Fine, and New” SMEs.
Category:
Time:2021-09-03
【概要描述】
Recently, Hebei Guangxiang Pharmaceutical Co., Ltd. and Hebei Guolong Pharmaceutical Co., Ltd., subsidiaries of Shijiazhuang Fourth Pharmaceutical Group, were both included in the sixth batch of provincial-level “Specialized, Fine, Distinctive, and Innovative” SMEs list.
Recently, Hebei Guangxiang Pharmaceutical Co., Ltd. and Hebei Guolong Pharmaceutical Co., Ltd., subsidiaries of Shijiazhuang Fourth Pharmaceutical Group, were both included in the sixth batch of provincial-level “Specialized, Fine, Distinctive, and Innovative” SMEs list.
It is reported that “specialized, refined, distinctive, and innovative” small and medium-sized enterprises (SMEs) are SMEs that possess four key strengths: specialization, refinement, distinctiveness, and innovation. They serve as a vital driving force behind economic and social development. Since launching the cultivation and certification program for “specialized, refined, distinctive, and innovative” SMEs in 2016, Hebei Province established a database for nurturing such enterprises in 2018 and initiated the selection of demonstration enterprises under the “specialized, refined, distinctive, and innovative” initiative in 2019, thereby creating a tiered cultivation system characterized by “entry into the database for nurturing, selective certification, demonstration enterprise selection, and the development of ‘little giants.’”
Shisi Pharmaceutical Group’s Guangxiang Pharmaceutical, based on bulk active pharmaceutical ingredients such as caffeine, metronidazole, theophylline, aminophylline, and nifedipine, is a major domestic industrial base for the production, R&D, and export of dozens of high-value-added specialty APIs—including abidol, pentoxifylline, rosuvastatin calcium, and pitavastatin calcium—while steadily enhancing its market influence. Guangxiang Pharmaceutical has consistently placed R&D and innovation in active pharmaceutical ingredients at the heart of its strategy. It has successively established collaborations with research institutions such as Tsinghua University and Tianjin University, creating an enterprise-driven innovation system centered on industry-academia-research-application integration, technological platform development, and new product creation. By continuously promoting technological advancement and innovation, Guangxiang Pharmaceutical has effectively accelerated the industrialization of new achievements, providing robust momentum for the company’s transformation, upgrading, and differentiated competitiveness.
Shi Si Yao Group Guolong Pharmaceutical boasts significant advantages in the research and development and production of specialty active pharmaceutical ingredients. Its hydroxyethyl starch product series is uniquely produced within the province. Guolong Pharmaceutical has established a refined and highly efficient management system and set of procedures, equipped with comprehensive automated production control systems, logistics systems, supply chain systems, and cost management systems. By introducing internationally advanced technologies and deploying fully automated, information-based, and intelligent equipment, the company has achieved refined, standardized, and scientifically driven enterprise development.
Keywords:
Recommended
SERVICE HOTLINE
Zip Code: 052165
Address: No.9 Xingye Street, Gaocheng District, Shijiazhuang City, Hebei Province
Mobile site
E code
Business license